Cat.#: ACPP-1325
| Despition | Synaptotagmin 1 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1351 | Dopamine D2 Receptor Blocking Peptide (AC1351) | 250 µg | inquiry |
| ACPP-1743 | Human SCG5 Protein (AC1743) | 2 µg | inquiry |
| ACPP-1113 | Native Porcine GFAP Protein (AC1113) | 25 µl | inquiry |
| ACPP-1502 | Human DAG1 Protein (AC1502) | 2 µg | inquiry |
| ACPP-1121 | Recombinant Human GFAP Protein (AC1121) | 25 µl | inquiry |
| ACPP-1652 | Human WWC1 Protein (AC1652) | 5 µg | inquiry |
| ACPP-1240 | PAX5 Blocking Peptide (AC1240) | 250 µg | inquiry |
| ACPP-1815 | Human HAAO Protein (AC1815) | 2 µg | inquiry |
| ACPP-1607 | Mouse Leptin Protein, PEG (AC1607) | 20 µg | inquiry |
| ACPP-1790 | Rat MANF Protein (AC1790) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.